Epididymitis
Methodology & AI Transparency ⓘ
Epididymitis Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Designated in federal medical registries as N45.1, Epididymitis falls under Urology & Prostate management, where urinalysis/urine culture [Epididymitis N45.1] establishes baseline severity and rules out diagnostic mimics.
- 2 Real-world patient consensus: Clinical coding for Epididymitis uses ICD-10 N45.1 across Urology & Prostate specialty care.
- 3 Typical cash cost range: Primary evaluation for Epididymitis incorporates urinalysis/urine culture [Epididymitis N45.1] and symptom diary review.
- 4 Top reported side effects / signs: Longitudinal Epididymitis monitoring tracks IPSS Urinary Symptom in Epididymitis (N45.1: Score) toward 0 – 7 (mild symptoms) (N45.1).
Ask our AI Specialists anything about Epididymitis
What Is Epididymitis?
Designated in federal medical registries as N45.1, Epididymitis falls under Urology & Prostate management, where urinalysis/urine culture [Epididymitis N45.1] establishes baseline severity and rules out diagnostic mimics.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Epididymitis (N45.1) center on uropathogenic bacterial mucosal in Epididymitis (N45.1: adherence (cystitis) or). targeted urology & prostate interventions aim to normalize IPSS Urinary Symptom in Epididymitis (N45.1: Score).
Common Symptoms & Clinical Signs
- • Presentation of Epididymitis (N45.1): sudden severe flank-to-groin in Epididymitis (N45.1: colicky pain caused)
- • Secondary Epididymitis clinical sign: weak, hesitant, or in Epididymitis (N45.1: intermittent urinary stream)
- • Symptom flares in Epididymitis correlating with IPSS Urinary Symptom in Epididymitis (N45.1: Score) deviation outside 0 – 7 (mild symptoms) (N45.1)
- • Functional urology & prostate impact requiring urinalysis/urine culture [Epididymitis N45.1] evaluation (N45.1)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Epididymitis Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | N45.1 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Prostate (BPH), Bladder & Urinary Tract | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: IPSS Urinary Symptom in Epididymitis (N45.1: Score) | 0 – 7 (mild symptoms) (N45.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Urinalysis & Post-Void in Epididymitis (N45.1: Residual (PVR)) | Negative leukocyte/nitrite; PVR < 50 mL (N45.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Total PSA & in Epididymitis (N45.1: Serum Creatinine/eGFR) | Age-specific PSA; eGFR > 75 mL/min (N45.1) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Epididymitis
Treatment selection for Epididymitis depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Epididymitis)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Safety profile of semaglutide vs. Placebo: Which Works Better for The SELECT study? The long-term safety profile observed in the Semaglutide Effects on heart and blood vessel Outcomes in People with Overweight or Obesity (SELECT) study is consistent with previously reported semaglutide studies. Obesity (Silver Spring, Md.) • 2025-03-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 39948761 ↗ |
| Can This Approach Help? Inside the Latest Research on Finasteride in the treatment of benign prostatic hyperplasia. A urodynamic After 1 year's treatment, the reduction in symptom score and increase in flow rate were well maintained; the mean prostate volume was reduced by 14% and. British journal of urology • 1992-07-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 1379107 ↗ |
| New Insights on A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3: What a 354-Participant Study Found CT-152 resulted in depression symptom improvement and a favorable safety profile. Journal of affective disorders • 2025-11-01 • Phase III Randomized Trial | N = 354 | 87/100 | PMID 40378969 ↗ |
Epididymitis Patient Community & “People Like Me” Threads
Filter Epididymitis community threads and patient logs by age, biological sex, dosage, and treatment duration.